Whom should we ask? A systematic literature review of the arguments regarding the most accurate source of information for valuation of health states.

Described health state Experienced health state General public values Health state valuation Hypothetical health state Patient values

Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
Jun 2020
Historique:
accepted: 10 01 2020
pubmed: 6 2 2020
medline: 24 7 2020
entrez: 5 2 2020
Statut: ppublish

Résumé

To determine and critically evaluate the arguments in the published literature regarding the most accurate source of information for valuation of health states: values based on experienced health states (patient values) or values based on described health states (general public values).

Identifiants

pubmed: 32016683
doi: 10.1007/s11136-020-02426-4
pii: 10.1007/s11136-020-02426-4
pmc: PMC7253527
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1465-1482

Références

Nord, E. (1999). Cost-value analysis in health care. Cambridge: Cambridge University Press.
doi: 10.1017/CBO9780511609145
Brazier, J., Akehurst, R., Brennan, A., et al. (2005). Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy,4(4), 201–208.
pubmed: 16466271 doi: 10.2165/00148365-200504040-00002
Dolan, P. (2008). Developing methods that really do value the ‘Q’ in the QALY. Health Economics, Policy and Law,3(1), 69–77.
doi: 10.1017/S1744133107004355
Dolan, P., & Kahneman, D. (2008). Interpretations of utility and their implications for the valuation of health. The Economic Journal,118, 215–234.
doi: 10.1111/j.1468-0297.2007.02110.x
Dolan, P. (2009). NICE should value real experiences over hypothetical opinions. Nature,462(7269), 35.
pubmed: 19890311 doi: 10.1038/462035a
Drummond, M., Brixner, D., Gold, M., et al. (2009). Toward a consensus on the QALY. Value in Health,12(Suppl 1), s31–35.
pubmed: 19250129 doi: 10.1111/j.1524-4733.2009.00522.x
Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes. New York: Oxford University Press.
Hausman, D. M. (2015). Valuing health. Well-being, freedom, and suffering. New York: Oxford University Press.
Brazier, J., Rowen, D., Karimi, M., et al. (2018). Experienced-based utility and own health state valuation for a health state classification system: Why and how to do it. The European Journal of Health Economics,19, 881–891.
pubmed: 29022120 doi: 10.1007/s10198-017-0931-5
Brazier, J., Ratcliffe, J., Saloman, J., & Tsuchiya, A. (2016). Measuring and valuing health benefits for economic evaluation (2nd ed.). Oxford: Oxford University Press.
doi: 10.1093/med/9780198725923.001.0001
McPherson, K., Myers, J., Taylor, W. J., McNaughton, H. K., & Weatherall, M. (2004). Self-valuation and societal valuations of health state differ with disease severity in chronic and disabling conditions. Medical Care,42(11), 1143–1151.
pubmed: 15586842 doi: 10.1097/00005650-200411000-00014
Mann, R., Brazier, J., & Tsuchiya, A. (2009). A comparison of patient and general population weightings of the EQ-5D dimensions. Health Economics,18(3), 363–372.
pubmed: 18702081 doi: 10.1002/hec.1362
Burström, K., Johannesson, M., & Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population. Health Policy,76, 359–370.
pubmed: 16214258 doi: 10.1016/j.healthpol.2005.06.011
Krabbe, P. F. M., Tromp, N., Ruers, T. J. M., & van Riel, P. L. C. M. (2011). Are patients’ judgements of health status really different from the general population? Health and Quality of Life Outcomes,9, 31.
pubmed: 21569351 pmcid: 3113921 doi: 10.1186/1477-7525-9-31
McNamee, P. (2007). What difference does it make? The calculation of QALY gains from health profiles using patient and general population values. Health Policy,84, 321–331.
pubmed: 17574293 doi: 10.1016/j.healthpol.2007.05.004
Versteegh, M. M., & Brouwer, W. B. F. (2016). Patient and general public preferences for health states: A call to reconsider current guidelines. Social Science and Medicine,165, 66–74.
pubmed: 27497260 doi: 10.1016/j.socscimed.2016.07.043
Burström, K., Sun, S., Gerdtham, U. G., et al. (2014). Swedish experience-based value sets for EQ-5D health states. Quality of Life Research,23, 431–442.
pubmed: 23975375 doi: 10.1007/s11136-013-0496-4
Cubi-Molla, P., Shah, K., & Burström, K. (2018). Experience-based values: A framework for classifying different types of experience in health valuation research. Patient,11(3), 253–270.
pubmed: 29305706 doi: 10.1007/s40271-017-0292-2
Leidl, R., & Reitmeir, P. (2011). A value set for the EQ-5D based on experienced health states Development and testing for the German population. PharmacoEconomics,29(6), 521–534.
pubmed: 21247225 doi: 10.2165/11538380-000000000-00000
Sun, S., Chen, J., Kind, P., et al. (2015). Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China. Quality of Life Research,24, 693–703.
pubmed: 25246184 doi: 10.1007/s11136-014-0793-6
Leidl, R., & Reitmeir, P. (2017). An experience-based value set for the EQ-5D-5L in Germany. Value in Health,20, 1150–1156.
pubmed: 28964448 doi: 10.1016/j.jval.2017.04.019
Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
Kind, P. (2009). Valuing EQ-5D health states—A VAStly simpler solution? In J. Busschbach, R. Rabin, F. de Charro (Eds.), Proceedings of the 24th scientific plenary meeting of the EuroQol Group (pp. 319–337). Kijkduin-The Hague, The Netherlands Rotterdam: EuroQol Group Executive Office. Retrieved 9 September 2015.
Rand-Hendriksen, K., Augestad, L. A., Kristiansen, I. S., & Stavem, K. (2012). Comparison of hypothetical and experienced EQ-5D valuations: Relative weights of the five dimensions. Quality of Life Research,21, 1005–1012.
pubmed: 21932138 doi: 10.1007/s11136-011-0016-3
Leidl, R., Reitmeir, P., König, H. H., & Stark, R. (2012). The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease. Value in Health,15(1), 151–157.
pubmed: 22264983 doi: 10.1016/j.jval.2011.08.004
Wolff, J., Edwards, S., Richmond, S., Orr, S., & Rees, G. (2012). Evaluating interventions in health: A reconciliatory approach. Bioethics,26(9), 455–463.
pubmed: 21535065 doi: 10.1111/j.1467-8519.2011.01888.x
National Institute for Health and Care Excellence (NICE). (2013). Guide to the methods of technology appraisal 2013. London: National Institute for Health and Care Excellence: London. Retrieved 26 June, 2018, from https://www.nice.org.uk/process/pmg9/chapter/foreword .
The Dental and Pharmaceutical Benefits Agency (TLV). (2003). General guidelines for economic evaluations from the Pharmaceutical Benefits Board (LFNAR 2003:2). Stockholm: The Dental and Pharmaceutical Benefits Agency. Retrieved 26 June, 2018, from https://www.tlv.se/download/18.2e53241415e842ce95514e9/1510316396792/Guidelines-for-economic-evaluations-LFNAR-2003-2.pdf .
The Dental and Pharmaceutical Benefits Agency (TLV). (2017). General guidelines for economic evaluations from the Dental and Pharmaceutical Benefits Agency (TLVAR 2017:1). Stockholm: The Dental and Pharmaceutical Benefits Agency. Retrieved 26 June, 2018, from https://www.tlv.se/download/18.467926b615d084471ac3230c/1510316374332/TLVAR_2017_1.pdf .
Brouwer, W. B. F., Culyer, A. J., van Exel, N. J. A., & Rutten, F. F. H. (2008). Welfarism vs. extra-welfarism. Journal of Health Economics,27, 325–338.
pubmed: 18179835 doi: 10.1016/j.jhealeco.2007.07.003
Sandelowski, M. (2000). Whatever happened to qualitative description? Research in Nursing & Health,23, 334–340.
doi: 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G
Graneheim, U. H., & Lundman, B. (2004). Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Education Today,24(2), 105–112.
pubmed: 14769454 doi: 10.1016/j.nedt.2003.10.001
Ubel, P. A., Nord, E., Gold, M., Menzel, P., Prades, J. L., & Richardson, J. (2000). Improving value measurement in cost-effectiveness analysis. Medical Care,38(9), 892–901.
pubmed: 10982111 doi: 10.1097/00005650-200009000-00003
Ogorevc, M., Murovec, N., Fernandez, N. B., & Rupel, V. P. (2017). Questioning the differences between general public vs. patient based preferences towards EQ-5D-5L defined hypothetical health states. Health Policy,123, 166–172.
pubmed: 28410808 doi: 10.1016/j.healthpol.2017.03.011
Rowen, D., Zouraq, I. A., Chevrou-Severac, H., & van Hout, B. (2017). International regulations and recommendations for utility data for health technology assessment. PharmacoEconomics,35(Suppl 1), 11–19.
pubmed: 29052162 doi: 10.1007/s40273-017-0544-y
Ubel, P. A., Loewenstein, G., & Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Quality of Life Research,12, 599–607.
pubmed: 14516169 doi: 10.1023/A:1025119931010
Stamuli, E. (2011). Health outcomes in economic evaluation: who should value health? British Medical Bulletin,97, 197–210.
pubmed: 21285110 doi: 10.1093/bmb/ldr001
Lenert, L. A., Treadwell, J. R., & Schwartz, C. E. (1999). Associations between health status and utilities implications for policy. Medical Care,37(5), 479–489.
pubmed: 10335750 doi: 10.1097/00005650-199905000-00007
de Wit, G. A., Busschbach, J. J. V., & de Charro, F. T. H. (2000). Sensitivity and perspective in the valuation of health status: whose values count? Health Economics,9, 109–126.
pubmed: 10721013 doi: 10.1002/(SICI)1099-1050(200003)9:2<109::AID-HEC503>3.0.CO;2-L
Polsky, D., Willke, R. J., Scott, K., Schulman, K. A., & Glick, H. A. (2001). A comparison of scoring weights for the EUROQOL derived from patients and the general public. Health Economics,10, 27–37.
pubmed: 11180567 doi: 10.1002/1099-1050(200101)10:1<27::AID-HEC561>3.0.CO;2-R
Happich, M., & von Lengerke, T. (2005). Valuing the health state ‘tinnitus’: differences between patients and the general public. Hearing Research,207, 50–58.
pubmed: 15919164 doi: 10.1016/j.heares.2005.04.002
Garau, M., Shah, K. K., Mason, A. R., et al. (2011). Using QALYs in cancer A review of the methodological limitations. Pharmacoeconomics,29(8), 673–685.
pubmed: 21599035 doi: 10.2165/11588250-000000000-00000
Ratcliffe, J., Brazier, J., Palfreyman, S., & Michaels, J. (2007). A comparison of patient and population values for health states in varicose veins patients. Health Economics,16, 395–405.
pubmed: 17006963 doi: 10.1002/hec.1170
Gandjour, A. (2010). Theoretical foundation of patient v population preferences in calculating QALYs. Medical Decision Making,30, 57–63.
doi: 10.1177/0272989X10370488
Menzel, P., Dolan, P., Richardson, J., & Olsen, J. A. (2002). The role of adaptation to disability and disease in health state valuation: A preliminary normative analysis. Social Science and Medicine,55, 2149–2158.
pubmed: 12409128 doi: 10.1016/S0277-9536(01)00358-6
Edelaar-Peeters, Y., Putter, H., Snoek, G. J., et al. (2012). The influence of time and adaptation on health state valuations in patients with spinal cord injury. Medical Decision Making,32, 805–814.
pubmed: 22622845 doi: 10.1177/0272989X12447238
Myers, J. A., McPherson, K. M., Taylor, W. J., Weatherall, M., & McNaughton, H. K. (2003). Duration of condition is unrelated to health-state valuation on the EuroQol. Clinical Rehabilitation,17, 209–215.
pubmed: 12625663 doi: 10.1191/0269215503cr602oa
McTaggart-Cowan, H. M., O’Cathain, A., Tsuchiya, A., & Brazier, J. E. (2012). Using mixed methods research to explore the effect of an adaptation exercise on general population valuations of health states. Quality of Life Research,21, 465–473.
pubmed: 21901378 doi: 10.1007/s11136-011-9994-4
Daniels, N. (1985). Just health care. New York: Cambridge University Press.
doi: 10.1017/CBO9780511624971
Daniels, N. (2007). Just health. Meeting health needs fairly. New York: Cambridge University Press.
doi: 10.1017/CBO9780511809514
Sen, A. (1985). Commodities and capabilities. Amsterdam: North-Holland.
Sen, A. (1992). Inequality reexamined. Cambridge: Harvard University Press.
Nussbaum, M., & Sen, A. (Eds.). (1993). The quality of life. Oxford: Clarendon Press.

Auteurs

Gert Helgesson (G)

Stockholm Centre for Healthcare Ethics, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, 171 77, Stockholm, Sweden. gert.helgesson@ki.se.

Olivia Ernstsson (O)

QRC KI, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, 171 77, Stockholm, Sweden.

Mimmi Åström (M)

Health Outcomes and Economic Evaluation Research Group, Stockholm Centre for Healthcare Ethics, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, 171 77, Stockholm, Sweden.
Equity and Health Policy Research Group, Department of Global Public Health, Karolinska Institutet, 171 77, Stockholm, Sweden.
Health Care Services, Region Stockholm, 171 77, Stockholm, Sweden.

Kristina Burström (K)

Health Outcomes and Economic Evaluation Research Group, Stockholm Centre for Healthcare Ethics, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, 171 77, Stockholm, Sweden.
Equity and Health Policy Research Group, Department of Global Public Health, Karolinska Institutet, 171 77, Stockholm, Sweden.
Health Care Services, Region Stockholm, 171 77, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH